Saeed Fatenejad

4.9k citations

37 papers · 3.8k indexed · 1 hit paper · h-index 23

Impact in

Rheumatology top 0.1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 27
- Rheumatoid Arthritis Research and Therapies 24
- Systemic Lupus Erythematosus Research 10
- Spondyloarthritis Studies and Treatments 5
Hematology 12
- Autoimmune and Inflammatory Disorders Research 12

Co-authors: Lars Klareskog Joseph Wajdula Désirée van der Heijde Ronald Pedersen Joseph Craft L. Settas J Sany Karel Pavelká
Journals: Annals of the Rheumatic Diseases (9 papers)The Journal of Immunology (4 papers)Lara D. Veeken (2 papers)The Journal of Clinical Pharmacology (2 papers)Nature Medicine (1 paper)
Partner nations: United States Netherlands Russia

In The Last Decade

Saeed Fatenejad

36 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial 2004 · 1.4k citations

Peers

Countries citing papers authored by Saeed Fatenejad

Since Specialization

Citations

This map shows the geographic impact of Saeed Fatenejad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saeed Fatenejad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saeed Fatenejad more than expected).

Fields of papers citing papers by Saeed Fatenejad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saeed Fatenejad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saeed Fatenejad. The network helps show where Saeed Fatenejad may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Saeed Fatenejad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Saeed Fatenejad Line = papers co-authored together Saeed Fatenejad links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment Annals of the Rheumatic Diseases ·Eugen Feist, Roy Fleischmann, Saeed Fatenejad, Christine Barte, M Yousser, Dwi Rara Sania Rara Sania, Michael E. Luggen, Toshiya Okamoto, Samsonov MIu, Josef S Smolen	2024	3
2	Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment SHILAP Revista de lepidopterología ·Eugen Feist, Roy Fleischmann, Saeed Fatenejad, Christine Barte, M Yousser, Dwi Rara Sania Rara Sania, Michael E. Luggen, Е. Л. Насонов, Samsonov MIu, Josef S Smolen	2024	0
3	Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study SHILAP Revista de lepidopterología ·Eugen Feist, Saeed Fatenejad, M Yousser, 伸子逢坂, Michael E. Luggen, Е. Л. Насонов, Samsonov MIu, Josef S Smolen, Roy Fleischmann	2023	1
4	Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study Annals of the Rheumatic Diseases ·Eugen Feist, Saeed Fatenejad, M Yousser, 伸子逢坂, Michael E. Luggen, Toshiya Okamoto, Samsonov MIu, Josef S Smolen, Roy Fleischmann	2022	26
5	Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study Annals of the Rheumatic Diseases ·Toshiya Okamoto, Saeed Fatenejad, Eugen Feist, Mariana Ivanova, 伸子逢坂, D. G. Krechikova, Khadidja FOUKI, Samsonov MIu, Румен Стоилов, Е. В. Зонова, Mark C. Genovese	2021	50
6	Integrated Population Pharmacokinetics of Etanercept in Healthy Subjects and in Patients With Rheumatoid Arthritis Ankylosing Spondylitis The Journal of Clinical Pharmacology ·Simon Zhou, 恭平小町谷, Joan Korth‐Bradley, Donald G. Raible, Maria Palmisano, Thomas E. Hankins, Saeed Fatenejad, Thorir D. Bjornsson	2010	21
7	Treatment of Idiopathic Pulmonary Fibrosis with Etanercept: An Exploratory, Placebo-controlled Trial American Journal of Respiratory and Critical Care Medicine ·Ganesh Raghu, Kevin M. Brown, Ulrich Costabel, Vincent Cottin, Roland M. du Bois, Joseph A. Lasky, Michiel Thomeer, James P. Utz, Rezaul Karim Khandker, Lawrence McDermott, Saeed Fatenejad	2008	264
8	Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial Annals of the Rheumatic Diseases ·Désirée van der Heijde, R. B. M. Landewé, Ronald van Vollenhoven, Saeed Fatenejad, Lars Klareskog	2008	79
9	Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study Annals of the Rheumatic Diseases ·Bernard Combe, Cătălin Codreanu, Ugo Fiocco, M. Gaubitz, Piet Geusens, Tore K Kvien, Karel Pavelká, P. Sambrook, Josef S Smolen, Rezaul Karim Khandker, Amitabh Singh, Joseph Wajdula, Saeed Fatenejad	2008	58
10	Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis Arthritis & Rheumatism ·Désirée van der Heijde, Lars Klareskog, Robert Landewé, George A. W. Bruyn, Alain Cantagrel, Patrick Durez, Gabriel Herrero‐Beaumont, Yair Molad, Cătălin Codreanu, Gabriele Valentini, Gizia da Silva Targino, Ron Pedersen, D. Gannon, Joseph Wajdula, Saeed Fatenejad	2007	166
11	Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis Annals of the Rheumatic Diseases ·Désirée van der Heijde, Stephanie Gerin, Maxime Dougados, Pál Géher, Irene van der Horst‐Bruinsma, Xavier Juanola, Ignazio Olivieri, F. Raeman, L. Settas, Joachim Sieper, Jacek Szechiński, David Walker, Komang Anggita Verdiana, Joseph Wajdula, L Paolozzi, Saeed Fatenejad	2006	102
12	Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: Two‐year clinical and radiographic results from the TEMPO study, a double‐blind, randomized trial Arthritis & Rheumatism ·Désirée van der Heijde, Lars Klareskog, Vicente Rodríguez‐Valverde, Cătălin Codreanu, H D Boloşiu, José Melo‐Gomes, Jesús Tornero-Molina, Joseph Wajdula, Ronald Pedersen, Saeed Fatenejad, (unknown)	2006	420
13	The Addition of Etanercept to Methotrexate and Methotrexate to Etanercept Monotherapies Improves Clinical Efficacy in Ra Patients Despite Low-Moderate Disease Activity at Baseline: Results of the TEMPO Extension Trial (Year 4) JCR Journal of Clinical Rheumatology ·D. van der Heijde, E. Martín Mola, Reijo Luukkainen, Stephan Rank, Saeed Fatenejad, F. Cook, D. Gannon, B Freundlich, David J. Chang	2006	1
14	Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial The Lancet ·Lars Klareskog, Désirée van der Heijde, J Jäger, Andrew Gough, Joachim R. Kalden, Michel Malaise, Emilio Martín Mola, Karel Pavelká, J Sany, L. Settas, Joseph Wajdula, Ronald Pedersen, Saeed Fatenejad, Marie Sanda Hit paper breakdown →	2004	1408
15	31. SWITCHING BIOLOGICS AFTER INITIAL ANTI-TUMOUR NECROSIS FACTOR-α FAILURE; SUCCESS WITH FURTHER TNF-α ANTAGONISM BUT FAILURE ON SUBSEQUENT INTERLEUKIN-1 RECEPTOR ANTAGONIST D. van der Heijde, Emil Yahya, Andrew Gough, Joachim R. Kalden, E. Martín Mola, L. Settas, Joseph Wajdula, Saeed Fatenejad, Marie Sanda, Jamilah Kadir, Gabriela Caffarena Celani, V. S. Sinyuk, Glaucia Lorena Ferreira, Victoria Bejarano, Robert McCauley, Domini Bryer, J. E. White, Paul Emery	2004	1
16	Unaltered Etanercept Pharmacokinetics With Concurrent Methotrexate in Patients With Rheumatoid Arthritis The Journal of Clinical Pharmacology ·Honghui Zhou, Philip R. Mayer, Joseph Wajdula, Saeed Fatenejad	2004	39
17	Autoreactive T cells in murine lupus Immunologic Research ·Joe Craft, Stanford L. Peng, Takao Fujii, Masato Okada, Saeed Fatenejad	1999	23
18	Central T Cell Tolerance in Lupus-Prone Mice: Influence of Autoimmune Background and the lpr Mutation The Journal of Immunology ·Saeed Fatenejad, Stanford L. Peng, Escabias Criado, Joe Craft	1998	26
19	Self antigens and epitope spreading in systemic autoimmunity Arthritis & Rheumatism ·Joe Craft, Saeed Fatenejad	1997	106
20	Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp- lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target. The Journal of Immunology ·Saeed Fatenejad, N. Y. Cho, Demetris Mylonas, Joseph Craft	1994	64

About Saeed Fatenejad

Saeed Fatenejad is a scholar working on Rheumatology, Hematology, Pathology and Forensic Medicine, Immunology and Genetics, having authored 37 papers that have together received 3.8k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (24 papers), Autoimmune and Inflammatory Disorders Research (12 papers), Systemic Lupus Erythematosus Research (10 papers), Lymphoma Diagnosis and Treatment (10 papers), T-cell and B-cell Immunology (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Spondyloarthritis Studies and Treatments (5 papers) and Immune Cell Function and Interaction (5 papers). The work is most often cited by research in Rheumatology (2.9k citations), Hematology (1.2k citations), Immunology (1.2k citations), Genetics (479 citations) and Pathology and Forensic Medicine (456 citations). Saeed Fatenejad has collaborated with scholars based in United States, Netherlands and Russia. Frequent co-authors include Lars Klareskog, Joseph Wajdula, Désirée van der Heijde, Ronald Pedersen, Joseph Craft, L. Settas, J Sany, Karel Pavelká, Marie Sanda and Andrew Gough. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Immunology, Lara D. Veeken, The Journal of Clinical Pharmacology and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact